Skip to main content
. 2020 Mar 24;35(6):1087–1093. doi: 10.1007/s00384-020-03559-1

Table 1.

Baseline characteristics

Stoma closure
n = 104
No stoma closure
n = 51
Male 53 (51.0%) 29 (56.9%)
Female 51 (49.0%) 22 (43.1%)
Age (years)
  −50 3 (2.9%) 5 (9.8%)
  50–60 22 (21.2%) 6 (11.8%)
  60–70 35 (33.7%) 16 (31.4%)
  70–80 34 (32.7%) 13 (25.5%)
  80+ 10 (9.6%) 11 (21.6%)
BMI (kg/m2) 25 (17–38) 24 (18–40)
  BMI ≤ 30 80 (85.1%) 39 (83.0%)
  BMI > 30 14 (14.9%) 8 (17.0%)
ASA-classification
  ASA 1–2 81 (77.9%) 33 (64.7%)
  ASA 3–5 23 (22.1%) 18 (35.3%)
Duration of symptoms prior to presentation (days) 6 (0–173) 5 (0–154)
Preoperative hemoglobin (mmol/L) 8.8 (4.7–11.7) 8.5 (5.2–11.4)
Preoperative leukocyte count (× 109/L) 11.4 (4.1–27.2) 11.1 (4.7–24.0)
Preoperative C-reactive protein (mg/L) 10 (1–239) 22 (1–290)
Preoperative eGFR (mL/min/1.73 m2) 83 (32–154) 76 (12–130)
Clinical M-stage
  cM0 92 (91.1%) 32 (64.0%)
  cM1 9 (8.9%) 18 (36.0%)
Type of resection
  Sigmoidectomy 61 (58.7%) 26 (51.0%)
  Left hemicolectomy 20 (19.2%) 11 (21.6%)
  Subtotal colectomy 2 (1.9%) 3 (5.9%)
  Low anterior resection (partial mesorectal excision) 18 (17.3%) 6 (11.8%)
  Sigmoidectomy + right hemicolectomy 3 (2.9%) 4 (7.8%)
  Transverse colon resection 0 (0.0%) 1 (2.0%)
Approach of operation
  Open 92 (88.5%) 51 (100.0%)
  Laparoscopic 12 (11.5%) 0 (0.0%)
Stoma location
  Ileum 80 (76.9%) 37 (72.5%)
  Ascending colon 1 (1.0%) 3 (5.9%)
  Transverse colon 21 (20.2%) 7 (13.7%)
  Descending colon 2 (1.9%) 4 (7.8%)
Pathological tumor stage
  pT2 3 (2.9%) 0 (0.0%)
  pT3 74 (71.2%) 34 (66.7%)
  pT4 27 (26.0%) 17 (33.3%)
  pN0 48 (46.2%) 17 (33.3%)
  pN1 34 (32.7%) 19 (37.3%)
  pN2 22 (21.2%) 15 (29.4%)

Data are given as number of cases (%). Continuous variables were given as median (range)

BMI, body mass index; ASA, American Society of Anesthesiologists; eGFR, estimated glomerular filtration rate